Company / EPS (Basic)
Avanos Medical, Inc. EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$1.57
FY2025
5-year range
-$8.53 / $1.08
FY2021-FY2025
Trend
+81.6%
vs FY2024
Sector context
#132 of 160
Health Care
What the data says
Avanos Medical, Inc.'s eps (basic) of $-1.57 is lower than 82% of companies in the Health Care sector (FY2025). EPS (Basic) returned to growth in FY2025 after 2 years of decline, reaching $-1.57.
Based on SEC 10-K filings.
-1.57 in FY2025.
Declined from $-1.32 to $-1.57 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 160This company -$1.57 Sector average $1.57
▼
-199.7% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 81.6% year-over-year.
- Ranks #132 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2019.
- Lowest eps (basic) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.57 | +81.6% |
| FY2024 | -$8.53 | -546.2% |
| FY2023 | -$1.32 | -222.2% |
| FY2022 | $1.08 | +212.5% |
| FY2021 | -$0.96 | -57.4% |
| FY2020 | -$0.61 | -136.1% |
| FY2019 | $1.69 | +38.5% |
| FY2018 | $1.22 | -27.8% |
| FY2017 | $1.69 | +98.8% |
| FY2016 | $0.85 | +109.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026